PROCESSA PHARMACEUTICALS INC (PCSA) Stock Income Statement
NASDAQ:PCSA - Nasdaq - US74275C3043 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 11.46M | 20.26M | 11.57M | 6.44M | 3.94M | |||
| Research and Development | 5.80M | 10.71M | 6.09M | 2.38M | 1.53M | |||
| Selling, General, and Administrative Expenses | 5.66M | 8.76M | 4.69M | 3.26M | 1.61M | |||
| Operating Income | -11.46M | -20.26M | -11.57M | -6.44M | -3.94M | |||
| Interest Income/Expense | 335.50K | 101.20K | 11.60K | -278.00K | -25.10K | |||
| Non Recurring Items | 0.00 | -7.27M | -402.80K | -8.70M | N/A | |||
| Income Before Taxes | -11.12M | -27.42M | -11.96M | -15.41M | -3.96M | |||
| Income Tax | 0.00 | 0.00 | -530.60K | -1.00M | -602.70K | |||
| Net Income | -11.12M | -27.42M | -11.43M | -19.04M | -3.86M | |||
| EBITDA | -11.46M | -19.47M | -10.78M | -5.63M | -3.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.48 | -34.05 | -14.92 | -50.77 | -13.99 | |||
| Non GAAP EPS | N/A | -25.00 | -14.80 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD